Literature DB >> 395539

Aminoglycoside renal cortical kinetics: a clue to mechanisms of nephrotoxicity.

A Whelton.   

Abstract

In the presence of healthy renal tissues, aminoglycosides demonstrate important differences in quantitative renal cortical accumulation. These phenomena may correlate with clinical toxicity. Proximal tubular reabsorptive pathways appear to be of key significance in the production of high renal cortical drug concentrations. It appears that such drug transport can be blocked competitively. The presence of severe disease in renal tissues significantly influences the intrarenal distribution characteristics of antibiotics and is associated with reduced parenchymal concentration of all drugs, with the exception of doxycycline. Studies defining the intrarenal gradient characteristics of drugs provide us with a better understanding of factors of importance in appropriate antibiotic selection for the treatment of renal infections. The investigations also contribute to a better understanding of the mechanisms of antibiotic-induced nephrotoxicity and the potential clinical management by which such nephrotoxicity can be avoided. Study of the multiple physiologic and pathophysiologic factors that influence drug concentrations within the kidney should continue to provide us with information of both therapeutic and toxicologic value.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 395539

Source DB:  PubMed          Journal:  Prog Clin Biol Res        ISSN: 0361-7742


  2 in total

1.  Aminoglycoside induced nephrotoxicity: molecular modeling studies of calreticulin-gentamicin complex.

Authors:  Gururao Hariprasad; Manoj Kumar; Komal Rani; Punit Kaur; Alagiri Srinivasan
Journal:  J Mol Model       Date:  2011-11-16       Impact factor: 1.810

Review 2.  Xenobiotic metabolism: the effect of acute kidney injury on non-renal drug clearance and hepatic drug metabolism.

Authors:  John Dixon; Katie Lane; Iain Macphee; Barbara Philips
Journal:  Int J Mol Sci       Date:  2014-02-13       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.